AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2018

Feb 12, 2018

30870_dirs_2018-02-12_cd9932ab-c134-4d36-b472-c646207d4936.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2018-02-08

Reporting Person: Califf Robert (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-08	Non-Qualified Stock Option (right to buy)	$8.35	A	35000	Acquired	2028-02-08	Common Stock (35000)	Direct

Footnotes

F1: This option shall vest and become exercisable as to 35,000 shares divided into equal monthly installments such that the option shall be 100% vested on February 8, 2021.